UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 179 filers reported holding UNIQURE NV in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $173,789 | -75.2% | 25,900 | -58.9% | 0.00% | – |
| Q2 2023 | $700,994 | +136.0% | 63,039 | +279.8% | 0.00% | – |
| Q3 2022 | $297,000 | -9.2% | 16,600 | -6.2% | 0.00% | -100.0% |
| Q2 2022 | $327,000 | -34.2% | 17,700 | -36.3% | 0.00% | – |
| Q1 2022 | $497,000 | -42.5% | 27,800 | +1.4% | 0.00% | – |
| Q3 2021 | $864,000 | +46.7% | 27,414 | +45.3% | 0.00% | -100.0% |
| Q2 2021 | $589,000 | -51.8% | 18,863 | -48.6% | 0.00% | -50.0% |
| Q1 2021 | $1,222,000 | -2.1% | 36,711 | +9.3% | 0.00% | 0.0% |
| Q4 2020 | $1,248,000 | +37.4% | 33,581 | +33.1% | 0.00% | -33.3% |
| Q3 2020 | $908,000 | -21.5% | 25,233 | -0.3% | 0.00% | 0.0% |
| Q2 2020 | $1,157,000 | +470.0% | 25,312 | +462.5% | 0.00% | +200.0% |
| Q1 2020 | $203,000 | – | 4,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |